PRUITT MICHAEL D (CEO, Chairman) purchased 29.8% of their position (1K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $572.00 — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/23/2019ACC: 0001493152-19-013323
DirectorOfficer· CEO, Chairman
Since Aug 2018
+1K
Net shares
Net buyer
$572.00
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1K
Price / share
$0.57
Trade value
$572.00
% of position
29.8%
8/23/2019
3.36K→4.36K
Total
Net shares
+1K
Net value
$572.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/23/2019 | P · Purchase | +1K | $0.57 | $572.00 | 29.8% | 3.36K | 4.36K |
| Total | +1K | $572.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
DirectShares owned17.26K
Common Stock
IndirectShares owned30.96K
Series 1 Preferred Stock
IndirectShares owned330.00
Total
17.26K direct·31.29K indirect48.55K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 17.26K | Direct |
| Common Stock | 30.96K | Indirect |
| Series 1 Preferred Stock | 330.00 | Indirect |
| Total | 48.55K | 17.26K direct·31.29K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported